Genezen
PrivateLast Round
Series C
Jul 1, 2024
Total Funding Raised
$18.5M
Company Overview
Genezen is a biotechnology company that provides contract development and manufacturing services for viral vectors used in cell and gene therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Biotech Equipment, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genezen Comparables
Compare Genezen with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VIVEbiotech | 90% | |
| ViroCell Biologics | 88% | |
| Andelyn Biosciences | 87% |
Genezen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 1, 2024 | ||||
| Growth Equity | Nov 2, 2023 | ||||
| Growth Equity | Jan 5, 2021 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 12, 2025
Partnered with Humane Genomics for oncolytic virus therapy.
- Nov 7, 2025
Collaborating with Charlotte & Gwenyth Gray Foundation on CLN6 Batten Disease.
Recent news
Latest coverage and updates
- has_revenueAug 10, 2026
Genezen had revenue of $48M on Sep 1st '24.
- is_developingAug 4, 2026
Genezen Inc. is developing AAV9 gene replacement therapy for UBA5 disorder on Aug 4th '26.
- partners_withAug 3, 2026
Genezen Inc. partnered with Raiden Science on Aug 3rd '26.
Genezen Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Genezen's valuation, stock price, and market status.
Is Genezen a public or private company?
Genezen is a private company.
What is the current stock price of Genezen?
Genezen is a private company with no public stock price. No recent secondary market data is available.
How much is Genezen worth (valuation)?
Valuation information for Genezen is not publicly available.
Can I buy Genezen stock?
Genezen shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Genezen's last funding round?
Genezen's most recent funding round was Series C on July 1, 2024.
Who are the main investors in Genezen?
Investor information for Genezen is not publicly disclosed.
Will Genezen IPO soon?
No public IPO plans have been announced for Genezen.
How can I track Genezen secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genezen's secondary market activity and sign up for updates.